In addition, we also measured high sensitivity C-reactive protein (hsCRP) and amino terminal pro-brain natriuretic peptide (NT-proBNP), two biomarkers involved in cardiovascular disease, to investigate the possible mechanisms mediating the impact of A-FABP on the development of CAD. This evidence concerns the gene FABP4 and coronary artery disorder.